Market Overview

Amgen Close to Buying Onyx Pharmaceuticals for $125/Share -NY TImes

Related ONXX
How to Prepare for the New Year
UPDATE: Stifel Terminates Coverage on Onyx Pharmaceuticals Following Acquisition by Amgen
Related AMGN
These 3 Biotech Stocks Just Hit New Highs
Amgen Submits Biologics License Application For Investigational BiTE Immunotherapy Blinatumomab
The Tech Industry is Vanishing Before Our Eyes (Fox Business)

The New York Times is reporting that Amgen (NASDAQ: AMGN) is close to a deal to acquire Onyx Pharmaceuticals (NASDAQ: ONXX) for $125 per share. The deal could be announced on Monday, according to sources.

Onyx rejected an offer of $120 per share from Amgen. Onyx Pharmaceuticals closed Friday at $116.96.

Posted-In: NY TimesNews Rumors M&A

 

Related Articles (AMGN + ONXX)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters